Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 18,434
-317 (-1.69%)
Jul 17, 2026, 3:29 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 236.36 billion as of July 17, 2026. Its market cap has increased by 27.94% in one year.
Market Cap
236.36B
Enterprise Value
238.61B
Revenue
20.23B
Ranking
n/a
PE Ratio
64.94
Stock Price
18,434.00
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 236.36B, an increase of 70,426.58%. That is a compound annual growth rate of 29.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 236.36B | 21.28% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 466.92B |
| Ajanta Pharma | 425.72B |
| Gland Pharma | 409.96B |
| Emcure Pharmaceuticals | 339.42B |
| Wockhardt | 300.72B |
| Piramal Pharma | 227.82B |
| Eris Lifesciences | 201.35B |
| NATCO Pharma | 174.14B |